Das-001    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
11Myasthenia1

11. Myasthenia    [ 226 clinical trials,   172 drugs,   (DrugBank: 45 drugs),   43 drug target genes,   118 drug target pathways]
Searched query = "Myasthenia", "MG"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 226 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04226170
(ClinicalTrials.gov)
September 30, 20209/1/2020Study of Pyridostigmine With Ondansetron in Subjects With Anti-AchR Positive Myasthenia GravisA Phase II, Study to Evaluate the Safety and Tolerability of Pyridostigmine When Given With Ondansetron to Subjects With Anti-AchR Positive Myasthenia GravisMyasthenia GravisDrug: DAS-001DAS-MG, IncNULLNot yet recruiting18 YearsN/AAll24Phase 2United States